ChromaDex (CDXC) Set to Announce Quarterly Earnings on Wednesday

ChromaDex (NASDAQ:CDXC) is set to announce its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.03) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

ChromaDex Stock Performance

Shares of CDXC opened at $3.54 on Wednesday. The company’s fifty day moving average is $2.96 and its 200-day moving average is $1.97. ChromaDex has a 12 month low of $1.25 and a 12 month high of $4.65.

Analysts Set New Price Targets

Several equities analysts have weighed in on CDXC shares. Roth Mkm raised their target price on ChromaDex from $4.25 to $6.00 and gave the company a “buy” rating in a report on Tuesday, April 9th. StockNews.com started coverage on ChromaDex in a report on Sunday, March 3rd. They set a “strong-buy” rating on the stock.

ChromaDex Company Profile

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.